Save the Antibiotic Xenleta as a Last Resort
Xenleta (zen-LEH-tah, lefamulin) will be the first oral and IV med in a new class of "pleuromutilin" antibiotics.
Xenleta is approved for community-acquired pneumonia. It will be touted as an option for resistant infections due to its unique mechanism.
But Xenleta doesn't seem more effective than other antibiotics.